| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/19/1997 | US5658955 Synergistic nixture; vector gene therapy |
| 08/19/1997 | US5658953 Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders |
| 08/19/1997 | US5658952 1-[4-(4'-sulfanilyl)phenyl]urea and derivatives for the treatment of Leishmaniasis |
| 08/19/1997 | US5658951 Diphenylcyclopropyl analogs |
| 08/19/1997 | US5658950 Therapeutic agent for glaucoma and ocular hypotensive agent |
| 08/19/1997 | US5658949 Inhibition of tumor necrosis factor by retinoic acid |
| 08/19/1997 | US5658948 Lysine; histidine |
| 08/19/1997 | US5658947 Topically applying betulinic acid or derivative |
| 08/19/1997 | US5658946 Methods for the treatment of herpes virus infections |
| 08/19/1997 | US5658945 Anticancer agent; aids therapy; controlling infections |
| 08/19/1997 | US5658944 Anticholesterol agents |
| 08/19/1997 | US5658940 Inhibitors of tumor necrosis factor |
| 08/19/1997 | US5658938 Hypotensive agent, antiischmic agents |
| 08/19/1997 | US5658937 Administering l-histidine or salts which can be reduced to histidine to treat influenza, meningeal inflammation and respiratory system disorders, caused by viruses, bacteria, retrovirus and other microorganims |
| 08/19/1997 | US5658936 Administering dose of renin-angiotensin system inhibitor which modifies acutely systemic blood pressure by less than ten percent |
| 08/19/1997 | US5658935 Useful as inhibitors of thrombocyte aggregation, the metastasis of carcinoma cells and the binding of osteoclasts on bone surfaces |
| 08/19/1997 | US5658934 Aryl-substituted alkoxycarbonyl-1,4-dihydropyridine-5-carboxylic acid esters |
| 08/19/1997 | US5658933 Enzyme inhibitors of proline and lysine hydroxylases necessary for the biosynthesis of collagen; antifibrotic agents; respiratory, liver and skin disorders; atherosclerosis; antiscarring agents |
| 08/19/1997 | US5658932 Azacyclic compounds; cognitive function stimulants; alzheimer's disease |
| 08/19/1997 | US5658931 Administering a mixture of antiestrogens |
| 08/19/1997 | US5658929 Anticoagulants |
| 08/19/1997 | US5658928 Anticoagulants, antiinflammatory agents, antitumor agents,wound healing agents, osteoporosis |
| 08/19/1997 | US5658927 Antiestrogens, antitumor agents |
| 08/19/1997 | US5658925 Aminobenzoic acid derivatives |
| 08/19/1997 | US5658922 4-aza-pregnane 5α-reductase isozyme 1 inhibitors |
| 08/19/1997 | US5658921 Potent sigma receptor ligands; water solubility; symmetry |
| 08/19/1997 | US5658918 Purine-2,8-diones and pharmaceutically acceptable salts thereof |
| 08/19/1997 | US5658916 Drug active on the central nervous system, a process for the preparation thereof and pharmaceutical compositions containing it |
| 08/19/1997 | US5658914 Diphenylcyclopropyl analogs |
| 08/19/1997 | US5658913 Thiopyrazine derivatives; enzyme inhibitor of phase 1 reaction to prevent the formation of activated toxic intermediate metabolites and induce phase ll conjugation reactions to promote excretion of toxics |
| 08/19/1997 | US5658912 6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)carbostyril derivatives |
| 08/19/1997 | US5658911 Heteroarylpiperidines, and their use as antipsychotics and analgetics |
| 08/19/1997 | US5658910 Nicotinic acid esters |
| 08/19/1997 | US5658909 Inhibition of abnormally phosphorylated paired helical filament epitope formation |
| 08/19/1997 | US5658908 Opioid diarylmethylpiperazines and piperdines |
| 08/19/1997 | US5658907 Compounds and methods for inhibition of HIV and related viruses |
| 08/19/1997 | US5658906 Cysteine protease and serine protease inhibitors |
| 08/19/1997 | US5658905 Use of triazine compounds as anxiolytics |
| 08/19/1997 | US5658903 Cytokine inhibitors |
| 08/19/1997 | US5658902 Quinazolines as inhibitors of endothelin converting enzyme |
| 08/19/1997 | US5658901 2,3-dihydro-1-(2,2,2,-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepines |
| 08/19/1997 | US5658900 Application of carbamazepine and oxcarbazepine in the treatment of Parkinson's disease and parkinsonian syndromes |
| 08/19/1997 | US5658899 Acid addition salts of 2, 3, 4, 5-tetrahydro-1H-3-benzazepine compounds |
| 08/19/1997 | US5658898 Intravenous solutions for a derivative of staurosporine |
| 08/19/1997 | US5658897 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl phosphinyloxyalkyl or phosphonamidoalkyl as therapeutic agents |
| 08/19/1997 | US5658896 Water-soluble silicate polymer |
| 08/19/1997 | US5658894 Polyanionic cyclodextrin derivative in carrier for promoting healing of wounded tissue |
| 08/19/1997 | US5658893 Method for inhibition of rotavirus infection with carrageenan |
| 08/19/1997 | US5658892 Compound delivery using high-pressure impulse transients |
| 08/19/1997 | US5658891 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 08/19/1997 | US5658889 Method and compounds for aica riboside delivery and for lowering blood glucose |
| 08/19/1997 | US5658888 Enterokinesis stimulating action |
| 08/19/1997 | US5658887 Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivatite |
| 08/19/1997 | US5658881 Method for topical inhibition of the metabolic activity of cytochrome P450 |
| 08/19/1997 | US5658880 Prevent selectin binding; antiinflammatory, anticancer agents; aids therapy |
| 08/19/1997 | US5658786 DNA encoding rat taurine transporter and uses thereof |
| 08/19/1997 | US5658776 Generation of high titers of recombinant AAV vectors |
| 08/19/1997 | US5658774 Inhibiting growth of tumor cells expressing oncogenes by introducing in vitro dna sequence encoding interferon regulatory factor, expressing said sequence |
| 08/19/1997 | US5658767 Plant extract; vegetable oil; infant's formula |
| 08/19/1997 | US5658590 Treatment of attention-deficit/hyperactivity disorder |
| 08/19/1997 | US5658587 Transdermal patch |
| 08/19/1997 | US5658583 Hollow frame containing heating element, heat generating medium, pharmaceutical; drug delivery |
| 08/19/1997 | US5658581 Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained |
| 08/19/1997 | US5658578 Cosmetic composition |
| 08/19/1997 | US5658576 Method for combatting cellulitis or reducing localized fatty excesses |
| 08/19/1997 | US5658568 Cytotoxic drug therapy |
| 08/19/1997 | US5658560 Method of treating endotoxemia by administering tyloxapol |
| 08/19/1997 | US5658549 Inhalating drug comprising tetrafluoroethane/1,1,1,2-/ for treating respiratory system disorder |
| 08/19/1997 | CA2126208C Anti-obesity agent |
| 08/19/1997 | CA2008078C Use of dimethylpolysiloxane for the treatment of disorders of the gastrointestinal tract |
| 08/19/1997 | CA2007651C Anti-inflammatory 1-heteroaryloxindole-3-carboxamides |
| 08/19/1997 | CA2007353C Superficial therapeutic system comprising an antineoplastic active substance, particularly 5-fluorouracil |
| 08/19/1997 | CA1339314C Antipsychotic 4-¬4-(3-benzisothiazolyl)-1-piperazinyl|butyl bridged bicyclic imides |
| 08/19/1997 | CA1339313C Pyrimidine derivatives |
| 08/19/1997 | CA1339312C Process for the manufacture of carboxylic acid amides |
| 08/19/1997 | CA1339309C Antiparasitic agents |
| 08/17/1997 | CA2197611A1 Pseudopeptides derives from neurokinins and their preparation process |
| 08/15/1997 | CA2197599A1 Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses |
| 08/14/1997 | WO1997029198A1 Thrombin muteins as antidotes for thrombin inhibitors |
| 08/14/1997 | WO1997029196A1 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy |
| 08/14/1997 | WO1997029195A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 08/14/1997 | WO1997029185A1 Recombinant phages |
| 08/14/1997 | WO1997029183A2 Methods and compositions for transforming dendritic cells and activating t cells |
| 08/14/1997 | WO1997029170A1 Technical di- and triglyceride mixtures |
| 08/14/1997 | WO1997029133A1 Modified inulin |
| 08/14/1997 | WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a) |
| 08/14/1997 | WO1997029119A1 Fhit proteins and nucleic acids and methods based thereon |
| 08/14/1997 | WO1997029111A1 New cephem compounds and pharmaceutical use thereof |
| 08/14/1997 | WO1997029109A1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/14/1997 | WO1997029106A1 Coralyne analogs as topoisomerase inhibitors |
| 08/14/1997 | WO1997029101A1 Novel cyclic amino acids as pharmaceutical agents |
| 08/14/1997 | WO1997029100A1 Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof |
| 08/14/1997 | WO1997029092A1 Histamine h3 receptor ligands |
| 08/14/1997 | WO1997029067A1 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants |
| 08/14/1997 | WO1997028826A2 Contraceptive release systems with antibacterial and/or antiviral effect |
| 08/14/1997 | WO1997028825A2 Spermatogenesis control |
| 08/14/1997 | WO1997028824A1 Obesity protein compounds and formulations thereof |
| 08/14/1997 | WO1997028823A1 Method of using antacid agent and pharmaceutical preparation containing antacid agent |
| 08/14/1997 | WO1997028818A1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope |
| 08/14/1997 | WO1997028817A1 Receptor ligand-facilitated delivery of biologically active molecules |